PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Institute, Second Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Department of Neurology, First Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Department of Ultrasound, 941 Hospital of The Chinese People\'s Liberation Army, Xining, China.\', \'Department of Gastroenterology, First Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Department of Emergency, Second Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Department of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Department of Nosocomial Infection Control, Second Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Institute of Respiratory Diseases, Key Laboratory of Respiratory Diseases Research, Second Affiliated Hospital, Army Medical University, Chongqing, China.\', \'Department of Neurology, Second Affiliated Hospital, Army Medical University, Chongqing, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2217/fon-2021-0288
?:hasPublicationType
?:journal
  • Future oncology (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34189948
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Indications for and contraindications of immune checkpoint inhibitors in cancer patients with COVID-19 vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34189948>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34189948>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all